Human metapneumovirus and respiratory syncytial virus: subtle differences but comparable severity

Area of Science:

• Virology
• Pediatric Respiratory Illness
• Epidemiology

Background:

• Human metapneumovirus (hMPV) is a significant viral pathogen causing respiratory tract infections in children.
• hMPV infection can lead to severe illness, including pneumonia and bronchiolitis, necessitating hospitalization.
• Understanding hMPV's clinical profile and comparison with other common respiratory viruses like RSV is crucial for effective management.

Purpose of the Study:

• To investigate the clinical characteristics of hMPV infections in hospitalized children.
• To compare the clinical presentation and outcomes of hMPV with Respiratory Syncytial Virus (RSV).
• To assess the prevalence and utility of routine screening for hMPV in pediatric respiratory illness.

Main Methods:

• Retrospective analysis of pediatric patients with respiratory symptoms admitted to a tertiary care center.
• Nucleic acid amplification testing on nasopharyngeal specimens to detect hMPV.
• Comparison of clinical and demographic data between hMPV-positive, RSV-positive, and virus-negative patient groups.

Main Results:

• hMPV was the second most frequently detected virus after RSV.
• hMPV-infected children were older than RSV-infected children.
• Common diagnoses included pneumonia (37.5%) and bronchiolitis (31.2%), with frequent fever (37.5%), antibiotic use (81.2%), and ICU admission (37.5%).

Conclusions:

• hMPV is a major cause of severe pediatric respiratory illness, comparable in severity to RSV.
• hMPV infections tend to occur in a slightly older pediatric population compared to RSV.
• Routine screening for hMPV in hospitalized children with respiratory symptoms is recommended due to its prevalence and severity.